Treating diabetes today: a matter of selectivity of sulphonylureas

Oxidative stress and beta-cell dysfunction

(2010) Gisela Drews et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure†

(2010) Michael A Nauck et al.   Journal of Diabetes Investigation

Sulfonylurea action re-revisited

(2010) Susumu Seino et al.   Journal of Diabetes Investigation

The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs

(2009) C.-L. Zhang et al.   SCIENCE

Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic β-cell line, MIN6

(2008) Fumi Sawada et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy

(2008) George E. Billman   PHARMACOLOGY & THERAPEUTICS

Drugs acting on SUR1 to treat CNS ischemia and trauma

(2007) J SIMARD et al.   CURRENT OPINION IN PHARMACOLOGY